27 results on '"Grünig, Ekkehard"'
Search Results
2. Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study
3. Safety and effectiveness of standardized exercise training in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction (TRAIN-HFpEF-PH): study protocol for a randomized controlled multicenter trial
4. Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis
5. Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension
6. Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study.
7. Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension
8. Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up
9. Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)
10. Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
11. Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
12. Right heart size and function significantly correlate in patients with pulmonary arterial hypertension – a cross-sectional study
13. Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study.
14. A multicentric quality-control study of exercise Doppler echocardiography of the right heart and the pulmonary circulation. The RIGHT Heart International NETwork (RIGHT-NET).
15. Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study
16. Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study.
17. Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study
18. Acute effects of exercise on the inflammatory state in patients with idiopathic pulmonary arterial hypertension.
19. EIF2AK4 mutation as "second hit" in hereditary pulmonary arterial hypertension.
20. The German adaptation of the Cambridge pulmonary hypertension outcome review (CAMPHOR)
21. Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension.
22. Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study.
23. Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
24. Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension.
25. Exercise training in pulmonary arterial hypertension associated with connective tissue diseases.
26. Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
27. The German adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.